Search

Paul L Skatrud

from Knightstown, IN
Age ~73
Get Report
Also known as:
Paul Donna Skatrud, Paul D Skatrud, Paul K Skatrud, Paul C Skatrud, Paul D
Phone and address:
8343 Addison Ave, Ogden, IN 46148
Related to:
Donna D Crisp, 68Geoffrey D Koch, 45Nicole C Williams, 46Daniel T Fidago, 49Donna J Skatrud, 73Cynthia K Skatrud, 72David G Koch, 74Christa R Fidago, 44Erika M Skatrud, 39Donna Koch, 73
Connected to:
Michael J Skatrud, 51Anna M Skattum, 37Dag J Skattum, 63Dan D Skattum, 64Larry L Skatvold, 78Terry S Skaudis, 43Cindy M Skaug, 61Jillian D Skaug, 38Norma L Skaug, 101Thomas M Skaug, 72

Paul Skatrud Phones & Addresses

  • 8343 Addison Ave, Knightstown, IN 46148
  • Greenwood, IN
  • Indianapolis, IN

Work

Company: Monsanto Sep 2008 Address: St. Louis, MO USA Position: Biotechnology prospecting lead

Education

Degree: Ph.D. School / High School: Indiana University School of Medicine 1983 to 1986 Specialities: Molecular Biology, Pharmacology, Toxicology

Skills

Biotechnology • Drug Discovery • Genomics • Genetics • Drug Development • Life Sciences • Pharmaceutical Industry • Biochemistry • Technology Transfer • Lifesciences • Infectious Diseases • Molecular Genetics • Glp • Biomarkers • Protein Chemistry • Assay Development • Purification • Microbiology • Immunology • Protein Purification • Fermentation • Elisa • Dna • Biopharmaceuticals • Bioinformatics • Cell Culture • Agricultural Biotechnology • In Vitro • High Throughput Screening • Cell • Immunoassays • Virology • Cell Biology • Protein Expression • Pharmacology • Technology Acuisition • In Vivo • Vaccines • Sequencing • Proteomics • Animal Health

Languages

English • German

Industries

Biotechnology

Resumes

Resumes

Paul Skatrud Photo 1

President

View page
Location:
8343 south Addison Ave, Knightstown, IN 46148
Industry:
Biotechnology
Work:
Monsanto - St. Louis, MO USA since Sep 2008
Biotechnology Prospecting Lead
Elanco Animal Health, a division of Eli Lilly and Company - Greenfield, IN 2000 - 2008
Principal Research Scientist
Eli Lilly and Company - Indianapolis, IN USA Feb 1982 - Aug 2008
Principal Research Scientist
Miller Brewing Company - Milwaukee, WI USA Jun 1977 - Feb 1982
Research Associate
Education:
Indiana University School of Medicine 1983 - 1986
Ph.D., Molecular Biology, Pharmacology, Toxicology University of Wisconsin
MS, Microbiology Luther College 1970 - 1974
Bachelor of Arts (B.A.), Biology, General
Skills:
Biotechnology
Drug Discovery
Genomics
Genetics
Drug Development
Life Sciences
Pharmaceutical Industry
Biochemistry
Technology Transfer
Lifesciences
Infectious Diseases
Molecular Genetics
Glp
Biomarkers
Protein Chemistry
Assay Development
Purification
Microbiology
Immunology
Protein Purification
Fermentation
Elisa
Dna
Biopharmaceuticals
Bioinformatics
Cell Culture
Agricultural Biotechnology
In Vitro
High Throughput Screening
Cell
Immunoassays
Virology
Cell Biology
Protein Expression
Pharmacology
Technology Acuisition
In Vivo
Vaccines
Sequencing
Proteomics
Animal Health
Languages:
English
German

Publications

Us Patents

Streptococcus Pneumoniae Gene Sequence Ftsz

View page
US Patent:
6350866, Feb 26, 2002
Filed:
Dec 8, 1997
Appl. No.:
08/987146
Inventors:
Paul Luther Skatrud - Greenwood IN
Robert Brown Peery - Brownsburg IN
Q May Wang - Indianapolis IN
Pamela Kay Rockey - Franklin IN
Assignee:
Eli Lilly and Company - Minneapolis IN
International Classification:
C07H 2104
US Classification:
536 235, 536 231, 536 232, 536 237, 536 2432, 536 234, 4353201, 435 691, 435 71, 435 914, 435220, 4352523, 435471, 435212, 435 697
Abstract:
The invention provides isolated nucleic acid compounds encoding FtsZ of Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus Pneumoniae Gene Sequence Hi1648

View page
US Patent:
H002019, Apr 2, 2002
Filed:
Nov 23, 1998
Appl. No.:
09/198284
Inventors:
Paul Luther Skatrud - Greenwood IN
Robert Brown Peery - Brownsburg IN
Patti Jean Treadway - Greenwood IN
International Classification:
C07H 1900
US Classification:
536 221, 435 6
Abstract:
The invention provides isolated nucleic acid compounds encoding HI1648 of Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Streptococcus Pneumoniae Gene Hi0454

View page
US Patent:
H002071, Jul 1, 2003
Filed:
Dec 8, 1997
Appl. No.:
08/987147
Inventors:
Robert Brown Peery - Brownsburg IN
Paul Luther Skatrud - Greenwood IN
Michele Louise Young Bellido - Indianapolis IN
Patti Jean Treadway - Greenwood IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C12P 2104
US Classification:
435 712, 435 691, 435 693, 435 711, 435440, 435471, 4352523, 43525411, 4352572, 4353201, 435822, 536 231, 536 237, 536 2432
Abstract:
The invention provides isolated nucleic acid compounds encoding the 454 gene of. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.

Process For Preparing Lipid Ii

View page
US Patent:
7169919, Jan 30, 2007
Filed:
Apr 18, 2001
Appl. No.:
09/833647
Inventors:
Larry Chris Blaszczak - Indianapolis IN, US
Scott Carl Mauldin - Indianapolis IN, US
Paul Luther Skatrud - Greenwood IN, US
Michael Scott VanNieuwenhze - Indianapolis IN, US
Mohammad Sadegh Zia-Ebrahimi - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07H 1/06
C07H 1/08
C07H 5/04
C07H 5/06
C08B 37/00
US Classification:
536128, 536 553, 5361231, 53612313, 536124, 536127
Abstract:
A process is described for preparing a substrate for the transglycosylase enzymes of bacterial cell wall biosynthesis. The chemical synthesis makes available a sustainable and substantially pure source of supply of lipid II, including analogs thereof, that may be used in the identification of new therapeutic agents capable of disrupting steps in bacterial cell wall biosynthesis.

Multiple Drug Resistance Gene Atrd Of Aspergillus Nidulans

View page
US Patent:
20020164772, Nov 7, 2002
Filed:
Nov 20, 2001
Appl. No.:
09/758828
Inventors:
Paul Skatrud - Greenwood IN, US
Maarten de Waard - Wageningen, NL
Alan Andrade - Wageningen, NL
Robert Peery - Brownsburg IN, US
International Classification:
C07H021/02
C07H021/04
C12N001/14
C12N001/16
C12N001/18
US Classification:
435/254100, 536/023100
Abstract:
The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of atrD are also provided. The invention further provides assays which utilize these transformed host cells.

Recombinant Dna Expression Vectors And Dna Compounds That Encode Isopenicillin N Synthetase From Aspergillus Nidulans

View page
US Patent:
48852520, Dec 5, 1989
Filed:
Dec 14, 1987
Appl. No.:
7/133760
Inventors:
Thomas D. Ingolia - Indianapolis IN
Stephen W. Queener - Indianapolis IN
Paul L. Skatrud - Greenwood IN
Barbara J. Wiegel - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C12N 1500
C12N 120
C12N 114
C07H 1512
US Classification:
4352523
Abstract:
DNA compounds and recombinant DNA expression vectors that encode and drive expression in recombinant host cells of the isopenicillin N synthetase activity of Aspergillus nidulans are useful to produce isopenicillin N synthetase and to improve the yield of. beta. -lactam-containing antibiotics from antibiotic-producing organisms. The isopenicillin N synthetase gene of A. nidulans can be isolated from plasmid pOGOO4, available from the Northern Regional Research Center under the accession number NRRL B-18171.

Streptococcus Pneumoniae Gene Sequence Mray

View page
US Patent:
62710001, Aug 7, 2001
Filed:
Dec 8, 1997
Appl. No.:
8/986768
Inventors:
Jo Ann Hoskins - Indianapolis IN
Robert Brown Peery - Brownsburg IN
Paul Luther Skatrud - Greenwood IN
Michele Louise Young Bellido - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C12P 2106
US Classification:
435 693
Abstract:
The invention provides isolated nucleic acid compounds encoding enzyme mraY of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded enzyme, and a method for identifying compounds that inhibit said enzyme.

Biosynthetic Gene Muri From Streptococcus Pneumoniae

View page
US Patent:
59486457, Sep 7, 1999
Filed:
Dec 4, 1996
Appl. No.:
8/759907
Inventors:
Jo Ann Hoskins - Indianapolis IN
Franklin Harpold Norris - Indianapolis IN
Pamela Kay Rockey - Indianapolis IN
Paul Robert Rosteck - Indianapolis IN
Paul Luther Skatrud - Indianapolis IN
Patti Jean Treadway - Greenwood IN
Michele Louise Young Bellido - Indianapolis IN
Chyun-Yeh Earnest Wu - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianaplis IN
International Classification:
C12P 2106
C12P 2104
C12N 1500
C07H 2102
US Classification:
435 693
Abstract:
The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murI of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurI enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis.
Control profile
Paul L Skatrud from Knightstown, IN, age ~73 Get Report